AGP Picks
View all

Verano Announces Strong Third Quarter 2026 Financial Results Highlighted by $212 Million in Revenue and Year-Over-Year Organic Growth

Company generates revenue increase of $10 million, or 5%, and highest level of cash flow from operations in four years

CHICAGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the third quarter ended September 30, 2026, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

Third Quarter 2026 Financial Highlights

    For the Three Months Ended,     For the Nine Months Ended,  
($ in thousands)   September 30, 2026     September 30, 2025     September 30, 2026     September 30, 2025  
Revenues, net of Discounts   $ 212,443     $ 202,810     $ 638,539     $ 614,891  
Gross Profit     100,038       95,237       298,713       307,802  
Income from Operations     11,908       9,277       28,150       50,490  
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries     (4,065 )     (43,832 )     (35,299 )     (74,497 )
Adjusted EBITDA1     50,353       53,109       150,588       173,660  


Third Quarter 2026 Financial Highlights

  • Revenues, net of discounts, of $212 million, an increase of 5% versus the third quarter 2025.
  • Gross profit of $100 million or 47% of revenue.
  • SG&A expenses of $85 million or 40% of revenue.
  • Net Loss of $(4) million or (2)% of revenue.
  • Adjusted EBITDA1 of $50 million or 24% of revenue.
  • Net cash provided by operating activities of $49 million.
  • Capital expenditures of $13 million.

Third Quarter 2026 Year-To-Date Financial Highlights

  • Revenues, net of discounts, of $639 million, an increase of 4% year-over-year.
  • Gross profit of $299 million or 47% of revenue.
  • SG&A expenses of $263 million or 41% of revenue.
  • Net Loss of $(35) million or (6)% of revenue.
  • Adjusted EBITDA1 of $151 million or 24% of revenue.
  • Net cash provided by operating activities of $98 million.
  • Capital expenditures of $40 million.

Management Commentary

“I am proud of our teams for delivering another strong quarter, highlighted by a 5% increase in revenue, robust retail performance, and achieving our highest level of operating cash flow in four years,” said George Archos, Verano founder, Chairman and Chief Executive Officer.

“With year-to-date revenue up 4% by quarter-end on an annual basis, and exciting seasonal products and promotions set to launch during the busy holiday season, the completion of several retail and CPG enhancement projects on schedule by year-end, and multiple catalysts on the horizon – including the exciting launch of retail adult use sales in Virginia – we aim to close 2026 on a high note, and look forward to hitting the ground running in what we anticipate will be an exciting year for Verano and the industry in 2027.”

Third Quarter 2026 Financial Overview

Revenues, net of discounts, for the third quarter 2026 were $212 million, up from $203 million for the third quarter 2025.

Gross profit for the third quarter 2026 was $100 million or 47% of revenue, up from $95 million or 47% of revenue for the third quarter 2025.

SG&A expenses for the third quarter 2026 were $85 million or 40% of revenue, up from $81 million or 40% of revenue for the third quarter 2025.

Net loss for the third quarter 2026 was $(4) million or (2)% of revenue, versus $(44) million or (22)% of revenue for the third quarter 2025.

Adjusted EBITDA1 for the third quarter 2026 was $50 million or 24% of revenue.

Net cash provided by operating activities for the third quarter 2026 was $49 million, up from $26 million for the third quarter 2025.

Capital expenditures for the third quarter 2026 were $13 million, up from $8 million for the third quarter 2025.

Third Quarter 2026 Year-To-Date Financial Overview

Revenues, net of discounts, for the third quarter 2026 year-to-date were $639 million, up from $615 million year-over-year.

Gross profit for the third quarter 2026 year-to-date was $299 million or 47% of revenue, down from $308 million or 50% of revenue year-over-year.

SG&A expenses for the third quarter 2026 year-to-date were $263 million or 41% of revenue, up from $251 million or 41% of revenue year-over-year.

Net loss for the third quarter 2026 year-to-date was $(35) million or (6)% of revenue, versus $(74) million or (12)% of revenue year-over-year.

Adjusted EBITDA1 for the third quarter 2026 year-to-date was $151 million or 24% of revenue.

Net cash provided by operating activities for the third quarter 2026 year-to-date was $98 million, up from $39 million year-over-year.

Capital expenditures for the third quarter 2026 year-to-date were $40 million, up from $32 million year-over-year.

2026 Guidance

  • The Company raises its 2026 capital expenditures guidance range to $54 million to $60 million.

Third Quarter 2026 Operational Highlights 

  • Expanded Florida retail footprint with the opening of MÜV Bradfordville, the Company's 86th Florida dispensary and 163rd location nationwide.
  • Entered the cannabis beverage category with the debut of Easy Landings, the Company’s first national beverage brand. 

Subsequent Operational Highlights

  • Commemorated the opening of Zen Leaf Meriden in a new and enhanced location.
  • Opening Zen Leaf Ephrata in Pennsylvania on Friday, October 30th.
  • Current operations span 13 states, comprised of 163 dispensaries and 14 production facilities with more than 1.1 million square feet of cultivation capacity.

Balance Sheet and Liquidity

As of September 30, 2026, the Company’s current assets were $416 million, including cash and cash equivalents of $102 million. The Company had working capital of $301 million and total debt, net of issuance costs, of $390 million.

The Company’s outstanding shares of common stock were 72,934,412 as of September 30, 2026.

Conference Call and Webcast

A conference call and webcast with analysts and investors is scheduled for October 29, 2026 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results.

_________________________

1Adjusted EBITDA and Adjusted EBITDA as a percentage of revenue (“Adjusted EBITDA Margin”) are non-U.S. GAAP financial measures. Each is derived from EBITDA, another non-U.S. GAAP financial measure, and is defined in this news release in the section below titled “Non-U.S. GAAP Financial Measures.” The most directly comparable U.S. GAAP financial measure to Adjusted EBITDA is net income (loss) and the most directly comparable measure to Adjusted EBITDA Margin is net income (loss) as a percentage of revenue (“net income (loss) margin”). The reconciliation of (i) Adjusted EBITDA to U.S. GAAP net income (loss) and (ii) Adjusted EBITDA Margin to net income (loss) margin is set forth below in the tables included in this news release.

Non-U.S. GAAP Financial Measures

Verano uses non-U.S. GAAP financial information to evaluate the performance of the Company. The terms “EBITDA,” “Adjusted EBITDA,” and “Adjusted EBITDA Margin” do not have any standardized meaning prescribed within U.S. GAAP and therefore may not be comparable to similar measures presented by other companies. Accordingly, this non-U.S. GAAP financial information is intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with U.S. GAAP.

The Company calculates EBITDA as net income (loss) before interest expense, income tax expense, depreciation and amortization; Adjusted EBITDA as net income (loss) before net interest expense, income tax expense, depreciation and amortization and also excludes certain one-time extraordinary items and Adjusted EBITDA Margin as net income (loss) before net interest expense, income tax expense, depreciation and amortization and exclusion of certain one-time extraordinary items as a percentage of revenue. The calculations of the non-U.S. GAAP financial measures used in this news release and the reconciliations to the most comparable U.S. GAAP financial numbers are included in the tables below.

Management believes that this non-U.S. GAAP financial information is useful as a supplement to comparable U.S. GAAP financial information because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP information to supplement their U.S. GAAP results. Management reviews these non-U.S. GAAP financial measures on a regular basis and uses them, together with financial measures included in the Company’s financial statements, to evaluate and manage the performance of the Company’s operations. These measures should be evaluated only in conjunction with the comparable U.S. GAAP financial numbers reported by the Company.

About Verano
Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf™ and MÜV™ dispensary banners, and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Savvy™, The Essence™, Swift Lifts™, HYPHEN™, Encore™, Easy Landings™, BITS™, Avexia™, MÜV™, CTPharma™, and Verano™. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.

Contacts:
Investors
Verano
Aaron Miles
Chief Investment Officer
Investors@verano.com

Media
Verano
Steve Mazeika
Vice President, Communications
Steve.Mazeika@verano.com

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

Financial Information Tables

The following tables include select financial results and the reconciliations of the non-U.S. GAAP financial measures to the respective most directly comparable U.S. GAAP financial measures for the presented periods.

VERANO HOLDINGS CORP.
Highlights from Unaudited Interim Condensed Consolidated Statements of Operations

    For the Three Months Ended,     For the Nine Months Ended,  
    September 30, 2026     September 30, 2025     September 30, 2026     September 30, 2025  
($ in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Revenues, net of Discounts   $ 212,443     $ 202,810     $ 638,539     $ 614,891  
Cost of Goods Sold, net     112,405       107,573       339,826       307,089  
Gross Profit   $ 100,038     $ 95,237     $ 298,713     $ 307,802  
Gross Profit %     47 %     47 %     47 %     50 %
Operating Expenses:                                
Selling, General and Administrative Expenses     84,506       80,560       262,877       251,484  
Loss on Impairment of Held for Sale Assets     3,624       5,400       7,686       5,400  
Loss on Impairment of Fixed Assets     —       —       —       428  
Total Operating Expenses   $ 88,130     $ 85,960     $ 270,563     $ 257,312  
Income from Operations   $ 11,908     $ 9,277     $ 28,150     $ 50,490  
Other Income (Expense):                                
Loss on Disposal of Property, Plant and Equipment     (796 )     (620 )     (811 )     (916 )
Gain on Deconsolidation     —       —       —       4,739  
Gain (Loss) on Debt Extinguishment     —       (946 )     (5,738 )     1,938  
Interest Expense, net     (10,760 )     (13,212 )     (34,330 )     (40,981 )
Other Income (Expense), net     2,851       (9,890 )     (754 )     (8,825 )
Total Other Expense, net     (8,705 )     (24,668 )     (41,633 )     (44,045 )
Income (Loss) Before Provision for Income Taxes   $ 3,203     $ (15,391 )   $ (13,483 )   $ 6,445  
Provision for Income Tax Expense     (7,268 )     (28,441 )     (21,816 )     (80,942 )
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries   $ (4,065 )   $ (43,832 )   $ (35,299 )   $ (74,497 )


VERANO HOLDINGS CORP.

Highlights from Condensed Consolidated Balance Sheets

    As of  
    September 30, 2026     December 31, 2025  
($ in thousands)   (Unaudited)     (Audited)  
Cash and Cash Equivalents   $ 102,054     $ 82,724  
Other Current Assets     313,554       321,927  
Property, Plant and Equipment, net     497,571       492,473  
Intangible Assets, net     536,243       579,090  
Goodwill     161,009       161,009  
Other Long-Term Assets     96,865       104,371  
Total Assets   $ 1,707,296     $ 1,741,594  
                 
Total Current Liabilities     114,139       140,261  
Total Long-Term Liabilities     923,085       898,954  
Stockholders' Equity     671,888       704,156  
Non-Controlling Interest     (1,816 )     (1,777 )
Total Liabilities and Shareholders' Equity   $ 1,707,296     $ 1,741,594  


VERANO HOLDINGS CORP.

Reconciliation of Net Loss to EBITDA (Non-U.S. GAAP) and Adjusted EBITDA (Non-U.S. GAAP, Unaudited) 

    For the Three Months Ended,     For the Nine Months Ended,  
    September 30, 2026     September 30, 2025     September 30, 2026     September 30, 2025  
($ in thousands)   (Unaudited)     (Unaudited)     (Unaudited)     (Unaudited)  
Net Loss Attributable to Verano Holdings Corp. & Subsidiaries   $ (4,065 )   $ (43,832 )   $ (35,299 )   $ (74,497 )
Interest Expense, net     10,760       13,212       34,330       40,981  
Income Tax Expense     7,268       28,441       21,816       80,942  
Depreciation and Amortization     29,806       31,560       88,425       94,839  
EBITDA   $ 43,769     $ 29,381     $ 109,272     $ 142,265  
                                 
COGS Add-backs:                                
Acquisition, Transaction and Other Non-operating Costs     385       2,146       1,642       6,418  
Employee Stock Compensation     94       400       652       1,298  
                                 
SG&A Add-backs:                                
Acquisition, Transaction and Other Non-operating Costs     2,263       1,003       11,620       3,637  
Employee Stock Compensation     1,009       2,122       8,355       7,866  
                                 
Impairments     3,624       5,400       7,686       5,828  
                                 
Acquisition Adjustments and Other (Income) & Expense, net     (791 )     12,657       11,361       6,348  
                                 
Adjusted EBITDA1   $ 50,353     $ 53,109     $ 150,588     $ 173,660  
                                 
Net Loss Margin     (2 )%     (22 )%     (6 )%     (12 )%
Adjusted EBITDA Margin1     24 %     26 %     24 %     28 %

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Wire Burundi

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.